Politics

Tracking how politics and policy intersect with science and health care

Donald Trump Drug-Pricing
Pharma

Trump often goes off script. What does that mean for his drug pricing speech?

By Erin Mershon and Ed Silverman

Prescription opioid
Politics

Drug distributors get hauled to the Hill to face questions on opioids

By Lev Facher

Gottlieb
Politics

Gottlieb pushes back against criticism of ‘breakthrough’ designation

By Ike Swetlitz

Politics

FDA is ready to cope with wave of retirements, Gottlieb says

By Ike Swetlitz

Trump Pharma Tweets
Politics

Can Trump use the bully pulpit to lower drug prices? Don’t bet on it

By Erin Mershon

Piglets
Politics

FDA commissioner says genetically engineering animals and developing human gene therapies are intertwined

By Ike Swetlitz

Prescription Medication
Politics

PhRMA takes aim at Medicare drug program in new ad campaign

By Erin Mershon

Dr. Scott Gottlieb,
Politics

Federal kickback law might be used to bring down drug prices, FDA commissioner suggests

By Ike Swetlitz

Rush Holt
Health

Scientists alarmed by report White House may tighten limits on Chinese researchers in U.S.

By Ike Swetlitz

Dr. Kurt Rasmussen
Politics

Former Lilly researcher will lead government agency studying addiction treatments

By Lev Facher

Bill Gates STAT
Exclusive

Bill Gates got President Trump fired up about a universal flu vaccine — and also (maybe) got a job offer

By Helen Branswell

Trump healthcare leaders
Politics

Partners, Mayo Clinic among hospital systems quietly advising Trump on improving VA

By Priyanka Dayal McCluskey — Boston Globe

FDA campus
Politics

Two key FDA officials to retire, leaving three divisions without permanent leaders

By Ike Swetlitz

Righ To Try Ad Campaign
Politics

Koch-backed group launches new national ad push to advance ‘right to try’ legislation

By Erin Mershon

Alex Azar - Sworn In At The White House
Politics

Drug makers question idea to shake up how Medicare pays for certain drugs

By Erin Mershon and Ike Swetlitz

DEA Prescription Drug
Politics

DEA plan to stem supply of prescription drugs draws skepticism

By Lev Facher

Pills and money illustration
Politics

With a new slate of appointees, Trump’s FTC expected to take tough stand on drug industry

By Erin Mershon

Francis Collins w Narcan
Politics

NIH abruptly changes course on industry opioids partnership after ethics flags raised

By Lev Facher

D.C. Insight IMAGE
Politics

FDA official insists U.S. is catching up to Europe on biosimilar regulations, approvals

By Erin Mershon

Bernie Sanders
Politics

Bernie Sanders introduces bill to impose jail time for execs behind opioid crisis

By Lev Facher

Dr. Scott Gottlieb,
Politics

FDA to relax its review of some next-generation genetic tests

By Ike Swetlitz

Broken pills concept
Politics

FDA-designated ‘breakthrough’ therapies may not actually be scientific breakthroughs

By Ike Swetlitz

Diagnosis eye diabetes
Politics

FDA approves first AI software that can identify disease, no specialists needed

By Ike Swetlitz

CORY BOOKER
Pharmalot

Senator lashes out at drug makers for stock buybacks, but not cutting prices

By Ed Silverman

National Institutes of Health Director Dr. Francis Collins
Politics

NIH director: Agency is looking at alcohol industry influence ‘in a very aggressive way’

By Lev Facher

ACLU Attorney Brigitte Amiri
Politics

Justice for Jane Doe: A New York attorney becomes the face of a crucial abortion rights case

By Megan Thielking

Pregnancy and clinical trials
Politics

Here’s what’s in the FDA plan to include pregnant women in clinical trials

By Megan Thielking

Essure Bayer Healthcare
Politics

FDA puts restrictions on birth control implant but no recall

By Associated Press

The Readout LOUD

LISTEN: The FDA’s cold shoulder, the latest CAR-T contender, and how Grindr relates to personal genetics

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.